Removal of 3'-phosphoglycolate from DNA strand-break damage in an oligonucleotide substrate by recombinant human apurinic/apyrimidinic endonuclease 1.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMC 308086)

Published in Nucleic Acids Res on May 25, 1994

Authors

T A Winters1, W D Henner, P S Russell, A McCullough, T J Jorgensen

Author Affiliations

1: Department of Radiation Medicine, Vincent T. Lombardi Cancer Research Center, Georgetown University Medical Center, Washington, DC 20007.

Articles citing this

Identification of APN2, the Saccharomyces cerevisiae homolog of the major human AP endonuclease HAP1, and its role in the repair of abasic sites. Genes Dev (1998) 2.46

3'-phosphodiesterase activity of human apurinic/apyrimidinic endonuclease at DNA double-strand break ends. Nucleic Acids Res (1997) 1.72

APE1 is the major 3'-phosphoglycolate activity in human cell extracts. Nucleic Acids Res (2004) 1.42

Overview of base excision repair biochemistry. Curr Mol Pharmacol (2012) 1.36

DNA damage and repair: relevance to mechanisms of neurodegeneration. J Neuropathol Exp Neurol (2008) 1.25

3'-phosphodiesterase and 3'-->5' exonuclease activities of yeast Apn2 protein and requirement of these activities for repair of oxidative DNA damage. Mol Cell Biol (2001) 1.17

Inhibition of Ape1 nuclease activity by lead, iron, and cadmium. Environ Health Perspect (2004) 1.13

DNA strand breaks produced by oxidative stress in mammalian cells exhibit 3'-phosphoglycolate termini. Nucleic Acids Res (1995) 1.03

Ubiquitin ligase UBR3 regulates cellular levels of the essential DNA repair protein APE1 and is required for genome stability. Nucleic Acids Res (2011) 0.99

Aprataxin, causative gene product for EAOH/AOA1, repairs DNA single-strand breaks with damaged 3'-phosphate and 3'-phosphoglycolate ends. Nucleic Acids Res (2007) 0.98

Trans-complementation by human apurinic endonuclease (Ape) of hypersensitivity to DNA damage and spontaneous mutator phenotype in apn1-yeast. Nucleic Acids Res (1995) 0.94

WRN exonuclease activity is blocked by DNA termini harboring 3' obstructive groups. Mech Ageing Dev (2006) 0.94

The current state of eukaryotic DNA base damage and repair. Nucleic Acids Res (2015) 0.89

Solution structure of an oligonucleotide containing an abasic site: evidence for an unusual deoxyribose conformation. Nucleic Acids Res (2001) 0.88

Synthesis, characterization and solution structure of tethered oligonucleotides containing an internal 3'-phosphoglycolate, 5'-phosphate gapped lesion. Nucleic Acids Res (2002) 0.83

Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines. Br J Cancer (1999) 0.82

Identification of a residue critical for the excision of 3'-blocking ends in apurinic/apyrimidinic endonucleases of the Xth family. Nucleic Acids Res (2009) 0.80

Glycolate and 2-phosphoglycolate content of tissues measured by ion chromatography coupled to mass spectrometry. Anal Biochem (2011) 0.80

Removal of reactive oxygen species-induced 3'-blocked ends by XPF-ERCC1. Chem Res Toxicol (2011) 0.79

Exploiting base excision repair to improve therapeutic approaches for pancreatic cancer. Front Nutr (2015) 0.78

Human AP endonuclease 1: a potential marker for the prediction of environmental carcinogenesis risk. Oxid Med Cell Longev (2014) 0.78

In situ activity gel for DNA repair 3'-phosphodiesterase. Nucleic Acids Res (1997) 0.75

Articles cited by this

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (1988) 52.71

Separation of the phosphoric esters on the filter paper chromatogram. Nature (1949) 42.78

Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes. Proc Natl Acad Sci U S A (1991) 3.82

Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants. Nucleic Acids Res (1991) 2.96

gamma Ray induced deoxyribonucleic acid strand breaks. 3' Glycolate termini. J Biol Chem (1983) 2.41

Two distinct human DNA diesterases that hydrolyze 3'-blocking deoxyribose fragments from oxidized DNA. Nucleic Acids Res (1991) 2.22

Analysis of class II (hydrolytic) and class I (beta-lyase) apurinic/apyrimidinic endonucleases with a synthetic DNA substrate. Nucleic Acids Res (1990) 1.75

Mechanism of DNA cleavage and substrate recognition by a bovine apurinic endonuclease. Biochemistry (1989) 1.29

Human HeLa cell enzymes that remove phosphoglycolate 3'-end groups from DNA. Nucleic Acids Res (1992) 1.19

Formation of cytosine glycol and 5,6-dihydroxycytosine in deoxyribonucleic acid on treatment with osmium tetroxide. Biochem J (1986) 1.11

32P-postlabeling detection of radiation-induced DNA damage: identification and estimation of thymine glycols and phosphoglycolate termini. Biochemistry (1991) 1.10

Purification and amino-terminal amino acid sequence of an apurinic/apyrimidinic endonuclease from calf thymus. Nucleic Acids Res (1987) 1.10

Processing of model single-strand breaks in phi X-174 RF transfecting DNA by Escherichia coli. Radiat Res (1991) 1.03

Neocarzinostatin-mediated DNA damage in a model AGT.ACT site: mechanistic studies of thiol-sensitive partitioning of C4' DNA damage products. Biochemistry (1992) 1.02

Genotoxicity of bleomycin. Mutat Res (1991) 1.01

Synthesis by DNA polymerase I on bleomycin-treated deoxyribonucleic acid: a requirement for exonuclease III. Biochemistry (1981) 1.00

Nucleotide sequence of a cDNA for an apurinic/apyrimidinic endonuclease from HeLa cells. Nucleic Acids Res (1992) 0.90

Mechanism of phosphaturia elicited by administration of phosphonoformate in vivo. Am J Physiol (1988) 0.87

Termini generated at the site of the DNA breakage mediated by photoexcited promazines. Biochem Pharmacol (1986) 0.84

The human gene for apurinic/apyrimidinic endonuclease (HAP1): sequence and localization to chromosome 14 band q12. Nucleic Acids Res (1992) 0.80

Articles by these authors

Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation (1973) 6.01

Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol (1966) 5.59

Transplantation of small bowel in the rat: technical and immunological considerations. Surgery (1971) 5.05

Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response. J Immunol (1966) 4.49

Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63

Recombinant ATM protein complements the cellular A-T phenotype. Oncogene (1997) 2.95

Sites and structure of gamma radiation-induced DNA strand breaks. J Biol Chem (1982) 2.47

Adult Thymectomy: Effect on Recovery from Immunologic Depression in Mice. Science (1965) 2.41

gamma Ray induced deoxyribonucleic acid strand breaks. 3' Glycolate termini. J Biol Chem (1983) 2.41

Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med (1985) 2.34

Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation (1981) 2.22

The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat. J Immunol (1971) 2.17

A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant (2011) 2.16

Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet (1996) 2.06

Heart transplantation in congenic strains of mice. Transplant Proc (1973) 1.97

Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J Exp Med (1978) 1.95

Reaction of human lymphocytes in culture to components of the medium. Nature (1965) 1.92

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83

Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81

Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med (1981) 1.77

Humoral antibodies in renal allotransplantation in man. N Engl J Med (1970) 1.74

Enzyme action at 3' termini of ionizing radiation-induced DNA strand breaks. J Biol Chem (1983) 1.74

A closer look at water-related geologic activity on Mars. Science (2007) 1.71

Some effects of purified heterologous antihuman lymphocyte serum in man. Transplantation (1967) 1.62

Effect of adult thymectomy on the recovery from immunological depression induced by anti-lymphocyte serum. Surg Forum (1965) 1.60

Athabasca Valles, Mars: a lava-draped channel system. Science (2007) 1.58

Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. Cancer J Sci Am (2006) 1.58

Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study. Gastroenterology (1992) 1.57

Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet (1998) 1.55

Procurement of a whole pancreas and liver from the same cadaveric donor. Surgery (1989) 1.49

Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer. Ann Oncol (2001) 1.47

Intermittent chemotherapy in metastatic androgen-independent prostate cancer. Br J Cancer (2003) 1.46

bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res (1993) 1.43

Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation (1977) 1.40

All-silica single-mode optical fiber with photonic crystal cladding. Opt Lett (1996) 1.39

Skin graft rejection by beta 2-microglobulin-deficient mice. J Exp Med (1992) 1.37

Specificity of deoxyribonucleic acid cleavage by bleomycin, phleomycin, and tallysomycin. Biochemistry (1982) 1.36

Transfection of Escherichia coli spheroplasts. 3. Facilitation of transfection and stabilization of spheroplasts by different basic polymers. J Virol (1973) 1.34

Supercontinuum generation in tapered fibers. Opt Lett (2000) 1.31

Mechanism of DNA cleavage and substrate recognition by a bovine apurinic endonuclease. Biochemistry (1989) 1.29

Hyperparathyroidism during pregnancy. Am J Surg (1976) 1.29

Characterization of human Gadd45, a p53-regulated protein. J Biol Chem (1994) 1.29

Kidney transplants between mice of graded immunogenetic diversity. Transplant Proc (1973) 1.29

Diagnosis of intestinal microsporidiosis by examination of stool and duodenal aspirate with Weber's modified trichrome and Uvitex 2B strains. J Clin Microbiol (1995) 1.28

Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Cancer Res (1988) 1.27

Immunosuppression and temporary skin transplantation in the treatment of massive third degree burns. Ann Surg (1975) 1.26

Heterologous antilymphocyte sera and some of their effects. Transplantation (1967) 1.25

Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. Transplantation (1986) 1.24

Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med (1983) 1.23

Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant (2010) 1.23

Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res (1987) 1.23

A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation. Cancer (2001) 1.22

Negative regulation of the major human AP-endonuclease, a multifunctional protein. Biochemistry (1996) 1.22

p21WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis. Cancer Res (2000) 1.21

Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation (1984) 1.20

Human HeLa cell enzymes that remove phosphoglycolate 3'-end groups from DNA. Nucleic Acids Res (1992) 1.19

Acute destruction by humoral antibody of rat skin grafted to mice. J Immunol (1973) 1.19

A highly conserved endonuclease activity present in Escherichia coli, bovine, and human cells recognizes oxidative DNA damage at sites of pyrimidines. Mol Cell Biol (1987) 1.19

A technique for reconstruction of the urinary tract in renal transplantation. Surg Gynecol Obstet (1966) 1.19

Temporary skin transplantation and immunosuppression for extensive burns. N Engl J Med (1974) 1.19

Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med (1983) 1.18

Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant (2007) 1.18

Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients. Transplantation (1981) 1.18

Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines. Cancer Res (1988) 1.18

Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant (2007) 1.17

Induction of IA antigens in murine renal transplants. J Immunol (1985) 1.16

Acute destruction by humoral antibody of rat skin grafted to mice. J Exp Med (1973) 1.15

Analgesia in terminal malignant disease. Br Med J (1979) 1.14

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207. Hum Gene Ther (1999) 1.13

Glutathione transferase activity and isoenzyme composition in primary human breast cancers. Cancer Res (1990) 1.12

Antilymphocyte serum as an immunosuppressive agent. Ann Intern Med (1968) 1.12

Regulation of human insulin gene expression in transgenic mice. Nature (1986) 1.12

Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo. Transplantation (1988) 1.12

Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev (1995) 1.11

From the National Institutes of Health. Summary of a workshop on cytomegalovirus infections during organ transplantation. J Infect Dis (1979) 1.11

Evaluation in primate renal allograft recipients of monoclonal antibody to human T-cell subclasses. Transplant Proc (1981) 1.11

Endlessly single-mode photonic crystal fiber. Opt Lett (1997) 1.10

Destruction of rat skin grafts by humoral antibody. Transplant Proc (1973) 1.10

Purification and amino-terminal amino acid sequence of an apurinic/apyrimidinic endonuclease from calf thymus. Nucleic Acids Res (1987) 1.10

Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation (1996) 1.07

Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J Exp Med (1989) 1.07

The effect of infection on T lymphocyte subpopulations: a preliminary report. Int J Immunopharmacol (1981) 1.04

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support. J Clin Oncol (1989) 1.04

Sensitivity of long-standing xenografts of rat hearts to humoral antibodies. J Immunol (1979) 1.02

Prevalence of eating disorders and psychiatric comorbidity among children and adolescents. Indian Pediatr (2007) 1.02

Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway. Am J Transplant (2009) 1.02

Weekly high-dose calcitriol and docetaxel in advanced prostate cancer. Semin Oncol (2001) 1.02

Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies. Transplantation (1982) 1.01

The renal transplant patient with fever and pulmonary infiltrates: etiology, clinical manifestations, and management. Medicine (Baltimore) (1980) 1.01

Destruction of splenic transplantation antigens by a factor present in liver. J Immunol (1965) 1.01

Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring. Surgery (1976) 1.00

Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Res Treat (2005) 0.99

Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon. Ann Intern Med (1980) 0.99

Xenon 133 study of ventilation and perfusion in normal and transplanted dog lungs. J Appl Physiol (1967) 0.99

Transplantation. N Engl J Med (1979) 0.98

Mechanism of action of Micrococcus luteus gamma-endonuclease. Biochemistry (1987) 0.98

Use of antithymocyte globulin for reversal of acute allograft rejection. Transplantation (1979) 0.98

Solitary thermal shock waves and optical damage in optical fibers: the fiber fuse. Opt Lett (1988) 0.98

A comparison of the enzymatic and physicochemical properties of human glutathione transferase M4-4 and three other human Mu class enzymes. Arch Biochem Biophys (1994) 0.98